Wednesday, September 16, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Cautious Normal choppiness · VIX 16.8
The broader market is in the midst of an unusually severe, broad-based selloff — the vast majority of S&P 500 constituents are down sharply (single-day declines of 5-25%+ are common) with deeply negative 30-day returns across nearly every sector. Against that backdrop, a narrow group of names is bucking the trend: stocks trading near their 52-week highs with positive 5-day and 30-day momentum, often on idiosyncratic earnings or guidance catalysts, represent the most credible 5%+ upside candidates. Given how few names show genuine relative strength, this list is deliberately narrow and skews toward quality/defensive and earnings-driven winners rather than speculative rebounds.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | WAT | SKIP | — | $422.56 → $444.22 stop $392.14 |
Position cap reached — 92 of 20 slots in use. |
| #2 | PM | SKIP | — | $193.40 → $203.07 stop $180.83 |
Position cap reached — 92 of 20 slots in use. |
| #3 | RVTY | SKIP | — | $146.19 → $153.50 stop $136.10 |
Position cap reached — 92 of 20 slots in use. |
| #4 | BRK-B | SKIP | — | $522.73 → $548.87 stop $510.71 |
Position cap reached — 92 of 20 slots in use. |
Already open: SCHW (to Sep 17), TRGP (to Sep 17), AV.L (to Sep 17), PSN.L (to Sep 17), SMT.L (to Sep 18), ABBV (to Sep 19), EOG (to Sep 19), VRTX (to Sep 19), ADP (to Sep 19), MDLZ (to Sep 19), WBD (to Sep 19), BMY (to Sep 20) … and 80 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Waters makes laboratory instruments used in drug development, food safety, and environmental testing. The stock is steadily outperforming the market and its price is coiling tightly, which can precede a breakout move. The main risk is that its short-term momentum indicator (MACD) has turned slightly negative, hinting the rally could be losing a bit of steam.
Why the AI likes it
What could go wrong
Calibrated probability: 61% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.
What each AI analyst estimated
Philip Morris sells cigarettes and smoke-free nicotine products like IQOS around the world. The stock has a steady, healthy uptrend, is beating the overall market, and its price pattern is coiling tightly (a 'squeeze'), which often precedes a breakout move higher. The main risk is that this is normally a slow-moving, defensive stock, so a quick 5% pop isn't guaranteed even with good technicals.
Why the AI likes it
What could go wrong
Calibrated probability: 61% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.
What each AI analyst estimated
Revvity makes scientific instruments and diagnostic tools used in health and life-sciences research. The stock has jumped sharply over the past month and is far outpacing the broader market. The main risk is that it now looks overbought (RSI near 75), meaning the rally has run hot and could cool off or reverse.
Why the AI likes it
What could go wrong
Calibrated probability: 61% (raw model estimate: 62%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.
What each AI analyst estimated
Berkshire Hathaway is Warren Buffett's giant holding company, owning insurance businesses, railroads, and large stakes in companies like Apple and Coca-Cola. It's a defensive, quality name that's quietly outperforming the market with strong technicals, and a top insider (the General Counsel) recently bought shares, which is a vote of confidence. The main risk is that a company this large and steady rarely moves 5% quickly, so hitting the target within 30 days is a stretch even in a good trend.
Why the AI likes it
What could go wrong
Calibrated probability: 61% (raw model estimate: 68%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 70% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by October 16, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 29 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.